These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25060828)

  • 1. Linkage analysis and exome sequencing identify a novel mutation in KCTD7 in patients with progressive myoclonus epilepsy with ataxia.
    Farhan SM; Murphy LM; Robinson JF; Wang J; Siu VM; Rupar CA; Prasad AN; ; Hegele RA
    Epilepsia; 2014 Sep; 55(9):e106-11. PubMed ID: 25060828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutation in potassium channel related gene KCTD7 and progressive myoclonic epilepsy.
    Krabichler B; Rostasy K; Baumann M; Karall D; Scholl-Bürgi S; Schwarzer C; Gautsch K; Spreiz A; Kotzot D; Zschocke J; Fauth C; Haberlandt E
    Ann Hum Genet; 2012 Jul; 76(4):326-31. PubMed ID: 22606975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic variants in KCTD7 perturb neuronal K+ fluxes and glutamine transport.
    Moen MN; Fjær R; Hamdani EH; Laerdahl JK; Menchini RJ; Vigeland MD; Sheng Y; Undlien DE; Hassel B; Salih MA; El Khashab HY; Selmer KK; Chaudhry FA
    Brain; 2016 Dec; 139(Pt 12):3109-3120. PubMed ID: 27742667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of a potassium channel-related gene in progressive myoclonic epilepsy.
    Van Bogaert P; Azizieh R; Désir J; Aeby A; De Meirleir L; Laes JF; Christiaens F; Abramowicz MJ
    Ann Neurol; 2007 Jun; 61(6):579-86. PubMed ID: 17455289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound heterozygous
    Burke EA; Sturgeon M; Zastrow DB; Fernandez L; Prybol C; Marwaha S; Frothingham EP; Ward PA; Eng CM; Fresard L; Montgomery SB; Enns GM; Fisher PG; Wolfe LA; Harding B; Carrington B; Bishop K; Sood R; Huang Y; Elkahloun A; Toro C; Bassuk AG; Wheeler MT; Markello TC; Gahl WA; Malicdan MCV
    J Neurogenet; 2021; 35(2):74-83. PubMed ID: 33970744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene.
    Kousi M; Anttila V; Schulz A; Calafato S; Jakkula E; Riesch E; Myllykangas L; Kalimo H; Topçu M; Gökben S; Alehan F; Lemke JR; Alber M; Palotie A; Kopra O; Lehesjoki AE
    J Med Genet; 2012 Jun; 49(6):391-9. PubMed ID: 22693283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCTD7-related progressive myoclonic epilepsy: Report of 42 cases and review of literature.
    Yoganathan S; Whitney R; Thomas M; Danda S; Chettali AM; Prasad AN; Farhan SMK; AlSowat D; Abukhaled M; Aldhalaan H; Gowda VK; Kinhal UV; Bylappa AY; Konanki R; Lingappa L; Parchuri BM; Appendino JP; Scantlebury MH; Cunningham J; Hadjinicolaou A; El Achkar CM; Kamate M; Menon RN; Jose M; Riordan G; Kannan L; Jain V; Manokaran RK; Chau V; Donner EJ; Costain G; Minassian BA; Jain P
    Epilepsia; 2024 Mar; 65(3):709-724. PubMed ID: 38231304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCTD7-related progressive myoclonus epilepsy.
    Van Bogaert P
    Epileptic Disord; 2016 Sep; 18(S2):115-119. PubMed ID: 27629772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing identifies compound heterozygous KCTD7 mutations in a girl with progressivemyoclonus epilepsy.
    Mei L; Huang Y; Chen J; He X; Lin S; Liao L; Wang X; Huang X; Sha Y; Ji Z; Li P
    Clin Chim Acta; 2019 Jun; 493():87-91. PubMed ID: 30825425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK): a cause of progressive myoclonic epilepsy.
    Mahale RR; Tiwari R; Arunachal G; Padmanabha H; Mailankody P
    Acta Neurol Belg; 2022 Jun; 122(3):801-803. PubMed ID: 33725338
    [No Abstract]   [Full Text] [Related]  

  • 11. 'North Sea' progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation.
    Boissé Lomax L; Bayly MA; Hjalgrim H; Møller RS; Vlaar AM; Aaberg KM; Marquardt I; Gandolfo LC; Willemsen M; Kamsteeg EJ; O'Sullivan JD; Korenke GC; Bloem BR; de Coo IF; Verhagen JM; Said I; Prescott T; Stray-Pedersen A; Rasmussen M; Vears DF; Lehesjoki AE; Corbett MA; Bahlo M; Gecz J; Dibbens LM; Berkovic SF
    Brain; 2013 Apr; 136(Pt 4):1146-54. PubMed ID: 23449775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KCTD7-related progressive myoclonic epilepsy: report of three Indian families and review of literature.
    Narayanan DL; Somashekar PH; Majethia P; Shukla A
    Clin Dysmorphol; 2022 Jan; 31(1):6-10. PubMed ID: 34866617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations.
    Rubboli G; Franceschetti S; Berkovic SF; Canafoglia L; Gambardella A; Dibbens LM; Riguzzi P; Campieri C; Magaudda A; Tassinari CA; Michelucci R
    Epilepsia; 2011 Dec; 52(12):2356-63. PubMed ID: 22050460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial cases of progressive myoclonic epilepsy caused by maternal somatic mosaicism of a recurrent KCNC1 p.Arg320His mutation.
    Kim H; Lee S; Choi M; Kim H; Hwang H; Choi J; Chae JH; Kim KJ; Lim BC
    Brain Dev; 2018 May; 40(5):429-432. PubMed ID: 29428275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations.
    Nascimento FA; Andrade DM
    Epileptic Disord; 2016 Sep; 18(S2):135-138. PubMed ID: 27629860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenic gene variants and clinical phenotype features of 26 children with progressive myoclonic epilepsy].
    Zhang J; Zhang YH; Chen JY; Ji TY; Yang ZX; Yang XL; Sun W; Zhang LP; Wu XR
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):458-464. PubMed ID: 31216804
    [No Abstract]   [Full Text] [Related]  

  • 17. The molecular genetic bases of the progressive myoclonus epilepsies.
    Serratosa JM; Gardiner RM; Lehesjoki AE; Pennacchio LA; Myers RM
    Adv Neurol; 1999; 79():383-98. PubMed ID: 10514828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel homozygous splice-site mutation in SCARB2 is associated with progressive myoclonic epilepsy with renal failure.
    Yari A; Ali-Nejad RM; Saleh-Gohari N
    Neurol Sci; 2021 Dec; 42(12):5077-5085. PubMed ID: 33772352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal muscular atrophy associated with progressive myoclonic epilepsy: A rare condition caused by mutations in ASAH1.
    Rubboli G; Veggiotti P; Pini A; Berardinelli A; Cantalupo G; Bertini E; Tiziano FD; D'Amico A; Piazza E; Abiusi E; Fiori S; Pasini E; Darra F; Gobbi G; Michelucci R
    Epilepsia; 2015 May; 56(5):692-8. PubMed ID: 25847462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive myoclonic epilepsy: myoclonic epilepsy and ataxia due to KCNC1 mutation (MEAK): a case report and review of the literature.
    Barot N; Margiotta M; Nei M; Skidmore C
    Epileptic Disord; 2020 Oct; 22(5):654-658. PubMed ID: 32972906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.